This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Drug Discovery Enzymes Market

Drug Discovery Enzymes R&D by Pharmaceuticals Opens Doors for the Major Players. Find Out More Trends with FMI

Drug Discovery Enzymes Market by Product Type, End User & Region - Forecast 2022 – 2032

Drug Discovery Enzymes Market Outlook (2022-2032)

[306 Pages Report] The drug discovery enzymes market is likely be worth US$ 1,776.8 million by 2032, from its projected US$ 886.6 million in 2022. A 6.5% CAGR in the market is predicted, during the forecast period. The drug discovery enzymes market experienced a CAGR of 6.4% over the preceding period (2016–2021).

The drug discovery enzymes market share is projected to rise as more sectors, including biotechnology, pharmaceuticals, food and beverage, embrace these enzymes for various analyses. These industries are concentrating on finding additional enzymes in order to develop useful medications.

Report Attribute

Details

Drug Discovery Enzymes Market Value (2022)

US$ 886.6 Million

Drug Discovery Enzymes Market Anticipated Value (2032)

US$ 1,776.8 Million

Drug Discovery Enzymes Projected Growth Rate (2032)

6.5%

The demand for drug discovery enzymes to produce intermediates for the manufacture of active pharmaceutical ingredients (API) for effective medications is rising. However, in recent years, the biofuel industry has made extensive use of enzymes like lipase to convert free fatty acids.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Factors Influencing the Drug Discovery Enzymes Market?

Factors

Explanation

R&D

Companies in the pharmaceutical, biopharmaceutical, and medical device industries make significant investments in the creation of novel drugs and technologies that increase the adoption of drug discovery enzymes. However, in recent years, phase III and preclinical phases have received the lion's share of their funding.

An increase in R&D spending is one of the main factors influencing the worldwide drug discovery enzymes market. The necessity for various preclinical and clinical services during the drug discovery and development process is what motivates the growth.

Target Specific Drugs

As manufacturers use enzymes to create more relevant medications that target certain areas of action, the market for drug discovery enzymes is anticipated to expand throughout the forecast period.

Furthermore, to identify the R-ATA enzyme from soil bacteria, Kaneka Corporation and the University of Tokyo worked together in the biotechnology and development wing.

Innovations

The food business is using a finite amount of enzymes to extend food's shelf life and enhance flavor. MetXtra is a newly developed food enzyme in the market. The search for and production of novel enzymes for testing samples takes less time and money thanks to this new enzyme.

During the anticipated period, these factors are likely to drive the demand for drug discovery enzymes to rise. However, in recent years, research institutions have innovated and focused on drug discovery enzymes to expand application domains.

What are the Declining Factors in the Drug Discovery Enzymes Market?

Handling and safety hazards connected with enzymes, as well as increased sensitivity to temperature and pH, are expected to limit market expansion. Furthermore, high financial costs and difficulties in participant recruitment and retention slow down the market growth.

Additionally, deficiencies in the clinical research workforce, drug sponsor-imposed barriers, and barriers related to clinical research globalization may all harm the market growth.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Regional Insights

Review Asia-Pacific Drug Discovery Enzymes Market

Asia-Pacific is expected to be the fastest-growing drug discovery enzymes market during the forecast period. However, due to the introduction of novel enzymes used to treat various chronic illnesses, and a rise in the number of development strategies by major companies, are rising market growth in the region.

Furthermore, the region is growing rapidly due to the availability of highly skilled labor with low-cost charges and due to environmental regulation in recent years.

What is the North America Drug Discovery Enzymes Market Outlook?

In terms of pharmaceutical R&D investment, North America dominates the drug discovery enzymes market during the forecast period. It is also the largest market for final dose formulations and bulk pharmaceuticals.

The market runs as a free economy, with transparent trading procedures and restrictions on anti-competitive behaviors. The region adopted high techniques with well-established infrastructure, which propelled the drug discovery enzymes market growth in recent years.

The United States market is expected to become one of the primary competitors for biosimilars by 2020. Remicade, Enbrel, Rituximab, Adalimumab, Infliximab, Etanercept, Darbepoetin Alpha, and other major medications are available in the US market. As a result of the aforementioned reasons, the market is expected to develop rapidly over the projected period.

Start-Up Ecosystem

How Start-Ups Companies Innovating in the Drug Discovery Enzymes Market?

To untangle the drug discovery process. Artificial intelligence and machine learning have given the pharmaceutical business new hope. AI tools enable researchers to rapidly develop innovative medications with the required features. Using these new methods, several businesses are developing innovative medicinal compounds. Some notable start-up companies are as under:

  • Standigm: Standigm, a South Korean start-up formed in 2015, uses AI to identify medications, saving time and money when compared to traditional approaches. Standigm BEST, their AI platform, is designed to explore latent chemical space to develop unique compounds with required attributes. In addition to chemical data, they evaluate biological literature to accelerate de novo drug creation.
  • Genesis Therapeutics: Genesis Therapeutics is a 2019 start-up situated in the United States. It combines artificial intelligence and biotechnology to speed the development of novel medications. For drug research and development, the business employs neural networks, biophysical modeling, and a scalable computing platform.
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

What is the Competitive Analysis of the Drug Discovery Enzymes Market?

Various prominent players are researching drug discovery enzymes in recent years. The pharmaceutical scientists are developing several drug enzymes that help to cure patients’ critical diseases in recent years.

Some recent developments in the Drug Discovery Enzymes industry are as follows:

  • In November 2020-Genesis Therapeutics and Genentech formed an AI-driven, multi-target drug development cooperation. Genesis' graph machine learning and drug discovery capabilities are used in this cooperation to uncover novel drug candidates for therapeutic targets across numerous disease categories.
  • In January 2020, Bayer signed a collaborative deal with the artificial intelligence drug discovery business Exscientia to develop and optimize innovative lead structures for prospective therapeutic candidates in the treatment of cardiovascular and oncological illnesses.

Some of the Key Participants Present in the Global Drug Discovery Enzymes Market Include

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 6.5% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in US$ million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Product Type
  • End User
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Sigma-Aldrich Co. LLC.
  • Kaneka Corporation
  • Actelion Pharmaceuticals Ltd
  • Genesis Biotechnology Group
  • Suven Life Sciences Limited
  • Enzo Life Sciences, Inc.
  • Merck KGaA

Customization

Available Upon Request

Key Segments

By Product Type:

  • Active Kinases
  • Ubiquitin
  • Epigenetic
  • Methyltransferases
  • Deacetylases
  • Phosphodiesterases
  • Others

By End User:

  • Pharmaceutical and Biotechnology Company
  • Research Institutes
  • Other End User

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

The drug discovery enzymes market is predicted to advance at a CAGR of 6.5% from 2022-to 2032.

The North America is anticipated to lead the drug discovery enzymes market through 2032.

The drug discovery enzymes market is likely to hold a valuation of US$1,776.8 million by 2032.

Research & Development sector is the key driver in the drug discovery enzymes market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2016-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2016-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032

        5.3.1. Active Kinases

        5.3.2. Ubiquitin

        5.3.3. Epigenetic

        5.3.4. Methyltransferases

        5.3.5. Deacetylases

        5.3.6. Phosphodiesterases

        5.3.7. Others

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2016-2021

    5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032

6. Global Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2016-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

        6.3.1. Pharmaceutical and Biotechnology Company

        6.3.2. Research Institutes

        6.3.3. Others

    6.4. Y-o-Y Growth Trend Analysis By End User, 2016-2021

    6.5. Absolute $ Opportunity Analysis By End User, 2022-2032

7. Global Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2016-2021

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Product Type

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Product Type

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Product Type

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By End User

    9.4. Key Takeaways

10. Europe Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Product Type

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By End User

    10.4. Key Takeaways

11. Asia Pacific Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. India

            11.2.1.5. Malaysia

            11.2.1.6. Singapore

            11.2.1.7. Australia

            11.2.1.8. New Zealand

            11.2.1.9. Rest of APAC

        11.2.2. By Product Type

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By End User

    11.4. Key Takeaways

12. MEA Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Israel

            12.2.1.4. Rest of MEA

        12.2.2. By Product Type

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By End User

    12.4. Key Takeaways

13. Key Countries Drug Discovery Enzymes Market Analysis

    13.1. U.S.

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2021

            13.1.2.1. By Product Type

            13.1.2.2. By End User

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2021

            13.2.2.1. By Product Type

            13.2.2.2. By End User

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2021

            13.3.2.1. By Product Type

            13.3.2.2. By End User

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2021

            13.4.2.1. By Product Type

            13.4.2.2. By End User

    13.5. Germany

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2021

            13.5.2.1. By Product Type

            13.5.2.2. By End User

    13.6. U.K.

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2021

            13.6.2.1. By Product Type

            13.6.2.2. By End User

    13.7. France

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2021

            13.7.2.1. By Product Type

            13.7.2.2. By End User

    13.8. Spain

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2021

            13.8.2.1. By Product Type

            13.8.2.2. By End User

    13.9. Italy

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2021

            13.9.2.1. By Product Type

            13.9.2.2. By End User

    13.10. China

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2021

            13.10.2.1. By Product Type

            13.10.2.2. By End User

    13.11. Japan

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2021

            13.11.2.1. By Product Type

            13.11.2.2. By End User

    13.12. South Korea

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2021

            13.12.2.1. By Product Type

            13.12.2.2. By End User

    13.13. Malaysia

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2021

            13.13.2.1. By Product Type

            13.13.2.2. By End User

    13.14. Singapore

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2021

            13.14.2.1. By Product Type

            13.14.2.2. By End User

    13.15. Australia

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2021

            13.15.2.1. By Product Type

            13.15.2.2. By End User

    13.16. New Zealand

        13.16.1. Pricing Analysis

        13.16.2. Market Share Analysis, 2021

            13.16.2.1. By Product Type

            13.16.2.2. By End User

    13.17. GCC Countries

        13.17.1. Pricing Analysis

        13.17.2. Market Share Analysis, 2021

            13.17.2.1. By Product Type

            13.17.2.2. By End User

    13.18. South Africa

        13.18.1. Pricing Analysis

        13.18.2. Market Share Analysis, 2021

            13.18.2.1. By Product Type

            13.18.2.2. By End User

    13.19. Israel

        13.19.1. Pricing Analysis

        13.19.2. Market Share Analysis, 2021

            13.19.2.1. By Product Type

            13.19.2.2. By End User

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Product Type

        14.3.3. By End User

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. Sigma-Aldrich Co. LLC.

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

        15.1.2. Kaneka Corporation

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

        15.1.3. Actelion Pharmaceuticals Ltd

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

        15.1.4. Enzo Life Sciences

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

        15.1.5. Merck KGaA

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

        15.1.6. Suven Life Sciences Limited

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

        15.1.7. Genesis Biotechnology Group

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Region, 2016-2032

Table 2: Global Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Product Type, 2016-2032

Table 3: Global Drug Discovery Enzymes Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 4: North America Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 5: North America Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Product Type, 2016-2032

Table 6: North America Drug Discovery Enzymes Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 7: Latin America Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 8: Latin America Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Product Type, 2016-2032

Table 9: Latin America Drug Discovery Enzymes Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 10: Europe Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 11: Europe Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Product Type, 2016-2032

Table 12: Europe Drug Discovery Enzymes Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 13: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 14: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Product Type, 2016-2032

Table 15: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 16: MEA Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 17: MEA Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Product Type, 2016-2032

Table 18: MEA Drug Discovery Enzymes Market Value (US$ Mn) Forecast by End User, 2016-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Drug Discovery Enzymes Market Value (US$ Mn) by Product Type, 2022-2032

Figure 2: Global Drug Discovery Enzymes Market Value (US$ Mn) by End User, 2022-2032

Figure 3: Global Drug Discovery Enzymes Market Value (US$ Mn) by Region, 2022-2032

Figure 4: Global Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Region, 2016-2032

Figure 5: Global Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 6: Global Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 7: Global Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Product Type, 2016-2032

Figure 8: Global Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 9: Global Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 10: Global Drug Discovery Enzymes Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 11: Global Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 12: Global Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 13: Global Drug Discovery Enzymes Market Attractiveness by Product Type, 2022-2032

Figure 14: Global Drug Discovery Enzymes Market Attractiveness by End User, 2022-2032

Figure 15: Global Drug Discovery Enzymes Market Attractiveness by Region, 2022-2032

Figure 16: North America Drug Discovery Enzymes Market Value (US$ Mn) by Product Type, 2022-2032

Figure 17: North America Drug Discovery Enzymes Market Value (US$ Mn) by End User, 2022-2032

Figure 18: North America Drug Discovery Enzymes Market Value (US$ Mn) by Country, 2022-2032

Figure 19: North America Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 20: North America Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Product Type, 2016-2032

Figure 23: North America Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 24: North America Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 25: North America Drug Discovery Enzymes Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 26: North America Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 27: North America Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 28: North America Drug Discovery Enzymes Market Attractiveness by Product Type, 2022-2032

Figure 29: North America Drug Discovery Enzymes Market Attractiveness by End User, 2022-2032

Figure 30: North America Drug Discovery Enzymes Market Attractiveness by Country, 2022-2032

Figure 31: Latin America Drug Discovery Enzymes Market Value (US$ Mn) by Product Type, 2022-2032

Figure 32: Latin America Drug Discovery Enzymes Market Value (US$ Mn) by End User, 2022-2032

Figure 33: Latin America Drug Discovery Enzymes Market Value (US$ Mn) by Country, 2022-2032

Figure 34: Latin America Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 35: Latin America Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Product Type, 2016-2032

Figure 38: Latin America Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 39: Latin America Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 40: Latin America Drug Discovery Enzymes Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 41: Latin America Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 42: Latin America Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 43: Latin America Drug Discovery Enzymes Market Attractiveness by Product Type, 2022-2032

Figure 44: Latin America Drug Discovery Enzymes Market Attractiveness by End User, 2022-2032

Figure 45: Latin America Drug Discovery Enzymes Market Attractiveness by Country, 2022-2032

Figure 46: Europe Drug Discovery Enzymes Market Value (US$ Mn) by Product Type, 2022-2032

Figure 47: Europe Drug Discovery Enzymes Market Value (US$ Mn) by End User, 2022-2032

Figure 48: Europe Drug Discovery Enzymes Market Value (US$ Mn) by Country, 2022-2032

Figure 49: Europe Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 50: Europe Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Product Type, 2016-2032

Figure 53: Europe Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 54: Europe Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 55: Europe Drug Discovery Enzymes Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 56: Europe Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 57: Europe Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 58: Europe Drug Discovery Enzymes Market Attractiveness by Product Type, 2022-2032

Figure 59: Europe Drug Discovery Enzymes Market Attractiveness by End User, 2022-2032

Figure 60: Europe Drug Discovery Enzymes Market Attractiveness by Country, 2022-2032

Figure 61: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) by Product Type, 2022-2032

Figure 62: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) by End User, 2022-2032

Figure 63: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) by Country, 2022-2032

Figure 64: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 65: Asia Pacific Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: Asia Pacific Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Product Type, 2016-2032

Figure 68: Asia Pacific Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 69: Asia Pacific Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 70: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 71: Asia Pacific Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 72: Asia Pacific Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 73: Asia Pacific Drug Discovery Enzymes Market Attractiveness by Product Type, 2022-2032

Figure 74: Asia Pacific Drug Discovery Enzymes Market Attractiveness by End User, 2022-2032

Figure 75: Asia Pacific Drug Discovery Enzymes Market Attractiveness by Country, 2022-2032

Figure 76: MEA Drug Discovery Enzymes Market Value (US$ Mn) by Product Type, 2022-2032

Figure 77: MEA Drug Discovery Enzymes Market Value (US$ Mn) by End User, 2022-2032

Figure 78: MEA Drug Discovery Enzymes Market Value (US$ Mn) by Country, 2022-2032

Figure 79: MEA Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 80: MEA Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: MEA Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: MEA Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Product Type, 2016-2032

Figure 83: MEA Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 84: MEA Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 85: MEA Drug Discovery Enzymes Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 86: MEA Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 87: MEA Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 88: MEA Drug Discovery Enzymes Market Attractiveness by Product Type, 2022-2032

Figure 89: MEA Drug Discovery Enzymes Market Attractiveness by End User, 2022-2032

Figure 90: MEA Drug Discovery Enzymes Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Antimetabolite Drugs Market

Published : June 2020

Healthcare

Drug of Abuse Testing Market

Published : November 2021

Healthcare

Injectable Drug Delivery Market

Published : December 2021

Google translate

Drug Discovery Enzymes Market